Innovations in Surgical Oncology at Roswell Park

For more than 120 years, Roswell Park Comprehensive Cancer Center in Buffalo, New York, has provided focused, comprehensive, and multidisciplinary care for cancer patients. Our focus has always been squarely on cancer – treating it, studying it, and training physicians and surgeons on how to do it better. Innovation in cancer care is at the heart of our practice. We strive to create new and better medical, surgical, and radiation oncology approaches across specialties to improve patient care and outcomes.

In this video, John M. Kane III, MD, FACS, chair of Surgical Oncology and Chief of the Melanoma/Sarcoma Service at Roswell Park, discusses some of the unique aspects of surgical oncology offered at the center and recent innovations in techniques.

Robot-assisted and minimally invasive surgical techniques for pancreatic cancers and upper GI malignancies are one of the specialties at Roswell Park experiencing innovative new approaches in recent years, including a unique robot-assisted approach to esophagectomy pioneered by our surgical teams.

Dr. Kane also discusses the long history and advances in technique and application of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) for a growing range of cancer types, coupled with new research working to improve clinical outcomes.

Additionally, in this video, Dr. Kane explains new clinical trials in extremity melanoma and sarcoma surgery led by Roswell Park investigators, including work in isolated limb perfusion and infusion in sarcoma, and a novel therapeutic agent called CDL-137 being studied in treating advanced extremity melanoma and sarcoma.

Recent work in robot-assisted colorectal cancer and surgical procedural innovations is also covered in Dr. Kane's discussion, including advances in treatment approaches for certain rectal cancer patients who may avoid surgery after neoadjuvant chemotherapy.


Created by

Roswell Park Comprehensive Cancer Center

Related Presenters

John M. Kane III, MD, FACS

John M. Kane III, MD, FACS

Chair, Surgical Oncology
Chief, Melanoma/Sarcoma Service, Department of Surgical Oncology
Program Director, Surgical Oncology Fellowship

I am an Associate Professor of Surgery and Chief of the Melanoma/Sarcoma service at Roswell Park Comprehensive Cancer Center. My interest in melanoma, sarcoma, and regional therapies dates back to the beginning of my practice in the year 2000.